On June 27, 2024, upon recommendation of the Nominating and Corporate Governance Committee, the Board of Directors of Vaxcyte, Inc. appointed John P. Furey to the Board as a Class II director, which appointment became effective on July 2, 2024. Mr. Furey's term will expire at the Company's annual meeting of stockholders in 2025. The Board also appointed Mr. Furey to serve as a member of the Compensation Committee of the Board.